Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
769.450.1%
QQQ
717.500.2%
BTC/USD
79574.480.1263%
DIA
532.880.22%
GLD
406.530.06%
TLT
82.240.04%

Purple Biotech Ltd

PPBTNASDAQ
Trade with Public
Trade with Public
$1.75
-0.23-11.62%
At close: Sep 4, 5:00 PM EST
$1.66
-0.09-5.14%
After Hours: 7:56 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentCompareOptionsStock Report

Purple Biotech Analyst Price Targets

Wall Street analyst price targets and consensus rating for Purple Biotech (PPBT).

Price Target Range — 7 Quarters

Analyst Consensus — 2 Analysts

2Buy
Consensus RatingBuy# Analysts2Avg. Consensus PT$14Upside to Avg. PT+743.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 7, 2026HC Wainwright & Co.Emily BodnarPT CutBuy$30→$17
Mar 13, 2026HC Wainwright & Co.Emily BodnarPT CutBuy$34→$30
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Purple Biotech, Lowers Price Target to $17

HC Wainwright & Co. analyst Emily Bodnar maintains Purple Biotech (NASDAQ:PPBT) with a Buy and lowers the price target from $30 to $17.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Purple Biotech, Maintains $33 Price Target

HC Wainwright & Co. analyst Emily Bodnar reiterates Purple Biotech (NASDAQ:PPBT) with a Buy and maintains $33 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Purple Biotech, Adjusts Price Target To $33 (1-20 Reverse Stock Split)

HC Wainwright & Co. analyst Emily Bodnar maintains Purple Biotech (NASDAQ:PPBT) with a Buy, adjusts target to $33 from $8 (1-20 Reverse Stock Split).
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Purple Biotech, Lowers Price Target to $8

HC Wainwright & Co. analyst Emily Bodnar maintains Purple Biotech (NASDAQ:PPBT) with a Buy and lowers the price target from $10 to $8.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Purple Biotech, Lowers Price Target to $8

HC Wainwright & Co. analyst Emily Bodnar maintains Purple Biotech (NASDAQ:PPBT) with a Buy and lowers the price target from $10 to $8.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Purple Biotech, Maintains $10 Price Target

HC Wainwright & Co. analyst Emily Bodnar reiterates Purple Biotech (NASDAQ:PPBT) with a Buy and maintains $10 price target.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved